Prev

Your Smartwatch Could Spot Neurological Problems Before You Notice—Here's What Researchers Found

Next

New research shows consumer smartwatches can detect early warning signs of serious neurological conditions like MS and myasthenia gravis, but doctors need better tools to interpret the data.

Consumer-grade smartwatches can detect early, clinically meaningful changes in neurological conditions like multiple sclerosis (MS), myasthenia gravis (MG), and migraine, according to new research from German neurologists. However, the data these devices collect requires careful interpretation by doctors, as external factors like vacations, infections, or mobility aids can skew the readings and lead to misleading conclusions.

Can Smartwatches Really Help Neurologists Monitor Patients?

Researchers at Heinrich-Heine University Düsseldorf conducted prospective observational trials over 6 to 24 months, equipping patients with neurological conditions with Withings ScanWatch devices to track their health in real-world settings. The study included patients with MS, MG, chronic inflammatory demyelinating polyneuropathy (CIDP)—a rare nerve disorder—and migraine. The findings suggest that wearable-generated data successfully captured early warning signs that mattered clinically, such as the onset of a myasthenic exacerbation, or sudden worsening of muscle weakness in MG patients.

What makes this research particularly valuable is that it moves beyond laboratory settings into everyday life. Unlike traditional doctor's office visits that happen every few months, smartwatches collect continuous data on heart rate, activity levels, and sleep patterns, offering a much more complete picture of how a patient's condition fluctuates day-to-day. For neurological conditions that are unpredictable and can change rapidly, this constant monitoring could mean catching problems earlier, when treatment is most effective.

What Did the Wearable Data Actually Reveal?

The research identified several concrete ways smartwatches proved useful for neurological care:

  • Early Detection of Flare-Ups: Wearable data successfully identified early signs of disease exacerbations, such as the sudden onset of worsening symptoms in myasthenia gravis patients, allowing doctors to intervene sooner.
  • Patient Self-Awareness: The devices helped patients better understand their own conditions by identifying individual triggers, particularly for migraine sufferers who could correlate activity patterns with headache onset.
  • Continuous Monitoring Between Visits: Rather than relying on patient memory during quarterly check-ups, smartwatches provide objective, real-time data on how symptoms evolve over weeks and months.

One particularly compelling finding was how wearables supported patient engagement. When people could see their own data visualized—showing how their activity, sleep, or heart rate patterns changed—they became more invested in understanding their condition and identifying what made their symptoms worse or better.

Why Can't Doctors Just Trust the Data?

Here's where the research hits a critical limitation: the data from smartwatches can be misleading if doctors don't understand the full context. External influences such as holidays, infections, or the use of mobility aids like canes or wheelchairs confounded the activity signals, making it difficult to know whether changes reflected actual disease progression or simply different daily circumstances. For example, a patient who takes a vacation and rests more might show reduced activity levels that look like disease worsening, when in reality they're just on holiday.

This is why the researchers emphasize that "wearables can enhance neurological care, their integration into clinical workflows is challenged by limited validation and interpretability." In other words, smartwatches are promising tools, but doctors need better training and clearer guidelines on how to interpret what the data actually means.

What Needs to Happen Next?

The research team identified several key requirements for making wearable monitoring truly useful in neurology:

  • Robust Clinical Validation: Smartwatch data needs to be tested and validated in formal clinical settings to establish which patterns reliably indicate disease changes versus normal variation.
  • Interoperable Platforms: Currently, data from different wearables and health apps don't easily communicate with each other or with electronic medical records, making it hard for doctors to incorporate the information into patient care.
  • Collaboration Between Disciplines: Realizing the potential of wearable monitoring requires close teamwork between clinicians who understand neurology, engineers who build the technology, and patients who use the devices daily.

The broader context here is that remote patient monitoring (RPM) is already reimbursed and widely used for conditions like heart failure, hypertension, and diabetes across the globe. Neurology is catching up, but it's a more complex field because neurological conditions often involve subtle, unpredictable symptom changes that are harder to quantify than, say, blood pressure readings.

For patients with rare neurological disorders like CIDP or MG, wearable monitoring could be especially transformative. These conditions often require patients to travel long distances to specialist centers for regular check-ups. Continuous monitoring at home could expand access to specialized care for people in remote locations or those with rare diseases who face challenges in regularly visiting expert centers.

The bottom line: your smartwatch has potential as a neurological monitoring tool, but it's not ready to replace your doctor's judgment. The technology works best when smartwatch data is combined with clinical expertise, contextual understanding of your life, and ongoing collaboration between you and your healthcare team.

Source

This article was created from the following source:

More from Health Technology